Cheryl Cohen
Chief Commercial Officer, Medivation.
Companies
- Celldex TherapeuticsBoard member Jun 17, 2022 to now1
- ImmunityBio, Inc.Board member Jun 7, 2019 to now2
- Lite Strategy, Inc.Board member Apr 14, 2020 to Jul 7, 20223
- Whitehawk Therapeutics, Inc.Board member Jun 22, 2018 to Jul 2, 20214
- Peak Bio, Inc.Board member Jan 27, 2021 to Jan 27, 20215
- Eledon Pharmaceuticals, Inc.Board member Apr 13, 2015 to Jul 15, 20196
- IMMUNIC, INC.Board member Jul 15, 2015 to Sep 14, 20187
- CytRxBoard member Jun 25, 2015 to Dec 17, 20158
- MedivationChief Commercial Officer Sep 8, 2011 to Feb 20, 20149
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ImmunityBio, Inc. IBRX125,386 shares10$1.3M at $10.00Jul 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 2, 2026Sold 131,210 shares at $9.50 of ImmunityBio, Inc.10
- Jul 2, 2026Exercised options 55,979 shares at $2.98 of ImmunityBio, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCelldex Therapeutics, Board member
- 2SEC EDGARImmunityBio, Inc., Board member
- 3SEC EDGARLite Strategy, Inc., Board member
- 4
- 5SEC EDGARPeak Bio, Inc., Board member
- 6
- 7SEC EDGARIMMUNIC, INC., Board member
- 8SEC EDGARCytRx, Board member
- 9SEC EDGARMedivation, Chief Commercial Officer
- 10